uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687)
Show others and affiliations
2012 (English)In: Journal of Medicinal Chemistry, ISSN 0022-2623, E-ISSN 1520-4804, Vol. 55, no 23, 10610-10629 p.Article in journal (Refereed) Published
Abstract [en]

A new series of pyrazinecarboxamide DGAT1 inhibitors was designed to address the need for a candidate drug with good potency, selectivity, and physical and DMPK properties combined with a low predicted dose in man. Rational design and optimization of this series led to the discovery of compound 30 (AZD7687), which met the project objectives for potency, selectivity, in particular over ACAT1, solubility, and preclinical PK profiles. This compound showed the anticipated excellent pharmacokinetic properties in human volunteers.

Place, publisher, year, edition, pages
2012. Vol. 55, no 23, 10610-10629 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-211228DOI: 10.1021/jm301296tPubMedID: 23116186OAI: oai:DiVA.org:uu-211228DiVA: diva2:666182
Available from: 2013-11-22 Created: 2013-11-21 Last updated: 2013-11-27Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Eriksson, Jan W
In the same journal
Journal of Medicinal Chemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 172 hits
ReferencesLink to record
Permanent link

Direct link